» Articles » PMID: 1773899

The Effect of Tumour Bearing on Skeletal Muscle Glutamine Metabolism

Overview
Journal Int J Biochem
Specialty Biochemistry
Date 1991 Jan 1
PMID 1773899
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

1. The effects of tumour bearing on glutamine metabolism in rat skeletal muscle were examined using the Walker 256 carcinosarcoma. 2. There was a rapid and marked decrease in skeletal muscle glutamine content, which was correlated with the size of the tumour, and a decrease in plasma glutamine concentration. 3. The rate of release of glutamine from EDL muscle in vitro was increased in cachectic, tumour bearing animals, but was unaffected from the soleus muscle of the same animals. 4. It is hypothesized that the increase in the rate of muscle glutamine release during cachexia represents a response of this tissue in order to satisfy the demand for glutamine by the tumour or by cells of the immune system.

Citing Articles

Exercise-Mediated Lowering of Glutamine Availability Suppresses Tumor Growth and Attenuates Muscle Wasting.

Pedersen K, Gatto F, Zerahn B, Nielsen J, Pedersen B, Hojman P iScience. 2020; 23(4):100978.

PMID: 32240949 PMC: 7114859. DOI: 10.1016/j.isci.2020.100978.


The Etiology and Impact of Muscle Wasting in Metastatic Cancer.

Biswas A, Acharyya S Cold Spring Harb Perspect Med. 2019; 10(10).

PMID: 31615873 PMC: 7528856. DOI: 10.1101/cshperspect.a037416.


Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis.

Chinopoulos C, Seyfried T ASN Neuro. 2019; 10:1759091418818261.

PMID: 30909720 PMC: 6311572. DOI: 10.1177/1759091418818261.


Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Schcolnik-Cabrera A, Chavez-Blanco A, Dominguez-Gomez G, Duenas-Gonzalez A Am J Cancer Res. 2017; 7(5):1107-1135.

PMID: 28560061 PMC: 5446478.


The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment.

Chen J, Chen Y, Vail G, Chow H, Zhang Y, Louie L Mol Neurodegener. 2016; 11(1):60.

PMID: 27538496 PMC: 4991002. DOI: 10.1186/s13024-016-0127-y.